{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:45:40Z","timestamp":1762098340423},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.4065\/82.2.196","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:29:19Z","timestamp":1232742559000},"page":"196-202","source":"Crossref","is-referenced-by-count":4,"title":["Eptifibatide vs Abciximab as Adjunctive Therapy During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction"],"prefix":"10.4065","volume":"82","author":[{"given":"Ganesh","family":"Raveendran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry H.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm R.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten Hall","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit S.","family":"Rihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/82.2.196_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials [published correction appears in Lancet. 2002;359: 2120]","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.4065\/82.2.196_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","author":"EPIC Investigation","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4065\/82.2.196_bib3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina [published correction appears in Lancet. 1997;350:744]","volume":"349","author":"CAPTURE Study","year":"1997","journal-title":"Lancet"},{"key":"10.4065\/82.2.196_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","author":"EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/82.2.196_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade","volume":"352","author":"EPISTENT Investigators (Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting)","year":"1998","journal-title":"Lancet"},{"key":"10.4065\/82.2.196_bib6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0735-1097(01)01290-6","article-title":"Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention","volume":"37","author":"Anderson","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/82.2.196_bib7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial [published correction appears in Lancet. 2001;357:1370]","volume":"356","author":"ESPRIT Investigators (Enhanced Suppression of the Platelet IIb\/IIIa Receptor with Integrilin Therapy)","year":"2000","journal-title":"Lancet"},{"key":"10.4065\/82.2.196_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","author":"PURSUIT Trial Investigators (Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy)","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/82.2.196_bib9","first-page":"1488","volume":"338","author":"Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators","year":"1998","journal-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction [published correction appears in N Engl J Med. 1998;339:415]"},{"key":"10.4065\/82.2.196_bib10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","author":"Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/82.2.196_bib11","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","article-title":"International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina","volume":"97","author":"PARAGON Investigators (Platelet IIb\/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network)","year":"1998","journal-title":"Circulation"},{"key":"10.4065\/82.2.196_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.98.8.734","article-title":"Randomized, placebo-controlled trial of platelet glycoprotein IIb\/IIIa blockade with primary angioplasty for acute myocardial infarction","volume":"98","author":"Brener","year":"1998","journal-title":"Circulation"},{"key":"10.4065\/82.2.196_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0735-1097(99)00635-X","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction","volume":"35","author":"Neumann","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/82.2.196_bib14","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/82.2.196_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4065\/82.2.196_bib16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2003.07.017","article-title":"A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction","volume":"42","author":"Antoniucci","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/82.2.196_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ahj.2003.08.011","article-title":"Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials","volume":"147","author":"Kandzari","year":"2004","journal-title":"Am Heart J"},{"key":"10.4065\/82.2.196_bib18","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.jacc.2003.09.010","article-title":"A preferred reperfusion strategy for acute myocardial infarction","volume":"42","author":"Topol","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/82.2.196_bib19","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA"},{"key":"10.4065\/82.2.196_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ccd.10351","article-title":"Platelet glycoprotein IIb\/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study [published correction appears in Catheter Cardiovasc Interv. 2003;59:419]","volume":"57","author":"Kaul","year":"2002","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611609981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611609981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T02:55:25Z","timestamp":1545447325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611609981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0025619611609981"],"URL":"https:\/\/doi.org\/10.4065\/82.2.196","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}